The global high potency active pharmaceutical ingredient (HPAPI) market is anticipated to grow at a considerable CAGR during the forecast period (2024-2031). The major factor driving the demand for the global high potency active pharmaceutical ingredients (HPAPI) market during the forecast period is the increasing demand for these drugs across the globe. The global HPAPI market is growing especially after the COVID-19 pandemic due to which governments focus on pharmaceutical raw materials like high potency active ingredients which drive the growth of the market.
Get Free Sample link @ https://www.omrglobal.com/request-sample/high-potency-active-pharmaceutical-ingredients-hpapi-market
Furthermore, targeted therapy is getting popular as compared to drugs or chemotherapy as it does not harm non-cancerous cells. Moreover, the growth of the market is also attributed to the increasing prevalence of cancer. According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1 million new cases globally in 2018 which is anticipated to rise to 29.5 million by 2040.
In addition, investment by pharmaceutical companies in R&D activities for expanding the HPAPI manufacturing sites and developing potent drugs will boost the market growth. For instance, in September 2020, Merck announced $65.2 million for the expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, US. However, special containment facilities require significant investment, transporting, and managing HPAPI which is extremely dangerous and costly as well as toxic to the health of associates working in manufacturing centers. These are some factors that act as a restriction for the growth of the global HPAPI market.
Full report of High Potency Active Pharmaceutical Ingredient (HPAPI) Market available @ https://www.omrglobal.com/industry-reports/high-potency-active-pharmaceutical-ingredients-hpapi-market
Market Coverage
Segment Covered-
- By Type
- By Type of Synthesis
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including BASF SE, Corden Pharma International GmbH, Cambrex Corp., CARBOGEN AMCIS AG, Dr. Reddy’s Laboratories Ltd., and Others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global High Potency Active Pharmaceutical Ingredient (HPAPI) Market Report Segment
By Type
- Innovative HPAPI
- Generic HPAPI
By Type of Synthesis
- Synthetic HPAPI
- Biotech HPAPI
By Application
- Oncology
- Glaucoma
- Hormonal Disorder
- Others (Respiratory Disorders, CVD, Diabetes, Cosmetology, and Erectile Dysfunction)
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/high-potency-active-pharmaceutical-ingredients-hpapi-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
